Alerus Financial’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.4M | Buy |
53,203
+13,787
| +35% | +$1.59M | 0.32% | 46 |
|
|
2025
Q4 | $4.15M | Buy |
39,416
+29,924
| +315% | +$2.81M | 0.2% | 77 |
|
|
2025
Q3 | $797K | Sell |
9,492
-320
| -3% | -$26.4K | 0.04% | 131 |
|
|
2025
Q2 | $777K | Sell |
9,812
-288
| -3% | -$22.9K | 0.06% | 120 |
|
|
2025
Q1 | $907K | Sell |
10,100
-226
| -2% | -$21.1K | 0.07% | 115 |
|
|
2024
Q4 | $1.03M | Sell |
10,326
-41,592
| -80% | -$4.29M | 0.08% | 108 |
|
|
2024
Q3 | $5.9M | Buy |
51,918
+228
| +0.4% | +$27.1K | 0.43% | 58 |
|
|
2024
Q2 | $6.4M | Sell |
51,690
-15,659
| -23% | -$2.02M | 0.48% | 52 |
|
|
2024
Q1 | $8.89M | Sell |
67,349
-411
| -0.6% | -$50.7K | 0.67% | 31 |
|
|
2023
Q4 | $7.39M | Buy |
67,760
+1,078
| +2% | +$112K | 0.6% | 41 |
|
|
2023
Q3 | $6.86M | Sell |
66,682
-5,893
| -8% | -$635K | 0.61% | 45 |
|
|
2023
Q2 | $8.37M | Sell |
72,575
-384
| -0.5% | -$43.6K | 0.71% | 38 |
|
|
2023
Q1 | $7.76M | Buy |
72,959
+910
| +1% | +$98.2K | 0.69% | 35 |
|
|
2022
Q4 | $7.99M | Sell |
72,049
-6,708
| -9% | -$686K | 0.73% | 33 |
|
|
2022
Q3 | $6.78M | Buy |
78,757
+2,203
| +3% | +$197K | 0.67% | 33 |
|
|
2022
Q2 | $6.98M | Sell |
76,554
-13,876
| -15% | -$1.23M | 0.65% | 31 |
|
|
2022
Q1 | $7.42M | Buy |
90,430
+18,650
| +26% | +$1.47M | 0.63% | 32 |
|
|
2021
Q4 | $5.5M | Buy |
71,780
+22,197
| +45% | +$1.77M | 0.45% | 55 |
|
|
2021
Q3 | $3.72M | Buy |
49,583
+1,454
| +3% | +$111K | 0.34% | 75 |
|
|
2021
Q2 | $3.74M | Buy |
48,129
+1,047
| +2% | +$77.9K | 0.38% | 71 |
|
|
2021
Q1 | $3.46M | Sell |
47,082
-3,602
| -7% | -$266K | 0.37% | 74 |
|
|
2020
Q4 | $3.96M | Buy |
50,684
+3,313
| +7% | +$253K | 0.4% | 65 |
|
|
2020
Q3 | $3.75M | Sell |
47,371
-63,505
| -57% | -$4.97M | 0.42% | 63 |
|
|
2020
Q2 | $8.18M | Sell |
110,876
-11,679
| -10% | -$879K | 0.96% | 20 |
|
|
2020
Q1 | $9M | Buy |
122,555
+6,603
| +6% | +$519K | 1.24% | 16 |
|
|
2019
Q4 | $10.1M | Buy |
115,952
+6,188
| +6% | +$508K | 1.15% | 18 |
|
|
2019
Q3 | $8.82M | Buy |
109,764
+4,528
| +4% | +$363K | 1.14% | 19 |
|
|
2019
Q2 | $8.42M | Buy |
105,236
+20,143
| +24% | +$1.54M | 1.14% | 18 |
|
|
2019
Q1 | $6.75M | Buy |
85,093
+41,352
| +95% | +$3.09M | 0.94% | 27 |
|
|
2018
Q4 | $3.19M | Sell |
43,741
-2,025
| -4% | -$143K | 0.49% | 55 |
|
|
2018
Q3 | $3.1M | Buy |
45,766
+16
| +0% | +$1.02K | 0.42% | 69 |
|
|
2018
Q2 | $2.65M | Sell |
45,750
-384
| -0.8% | -$21.7K | 0.38% | 79 |
|
|
2018
Q1 | $2.4M | Buy |
46,134
+934
| +2% | +$50.4K | 0.34% | 80 |
|
|
2017
Q4 | $2.43M | Buy |
45,200
+1,403
| +3% | +$77.8K | 0.34% | 75 |
|
|
2017
Q3 | $2.67M | Buy |
43,797
+458
| +1% | +$27.8K | 0.39% | 71 |
|
|
2017
Q2 | $2.65M | Buy |
43,339
+7,874
| +22% | +$479K | 0.39% | 71 |
|
|
2017
Q1 | $2.15M | Buy |
35,465
+932
| +3% | +$56.5K | 0.33% | 75 |
|
|
2016
Q4 | $1.94M | Buy |
34,533
+1,048
| +3% | +$61.3K | 0.31% | 76 |
|
|
2016
Q3 | $1.99M | Buy |
33,485
+1,526
| +5% | +$89.2K | 0.32% | 69 |
|
|
2016
Q2 | $1.76M | Buy |
+31,959
| New | +$1.7M | 0.29% | 79 |
|
Other funds holding MRK
VCM
VPM
Alerus Financial's MRK Position: Q1 2026 in Review
Alerus Financial increased its Merck (MRK) stake by 35% in Q1 2026, buying an estimated $1.59M and bringing the position to 53,203 shares worth $6.4M. The position accounts for 0.32% of the portfolio, ranked #46.
Alerus Financial first reported a position in MRK in Q2 2016 and has held it in 40 quarters since. The position peaked at $10.1M in Q4 2019. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Alerus Financial held 53,203 shares of Merck worth $6.4M as of Q1 2026.
- Alerus Financial bought 13,787 Merck shares in Q1 2026, an estimated $1.59M.
- Merck made up 0.32% of Alerus Financial's portfolio in Q1 2026, its #46 holding.
- Alerus Financial first reported a position in Merck in Q2 2016 and has held it in 40 quarters since.
- Alerus Financial's Merck position peaked at $10.1M in Q4 2019.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.